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ABSTRACT
Objective: To investigate the antibacterial activity of Zingiber officinale (ginger) Garcinia
kola (bitter kola) on four respiratory tract pathogens.
Design: A prospective study based on laboratory investigations.
Setting: Department of Life Sciences, University of Buea. Throat swabs were collected
from 333 individuals with running nostrils, cough and / or catarrh in three localities
of Buea namely Bokwango, Molyko and Bolifamba. Staphylococcus aureus, Streptococcus
pyogenes, Streptococcus pneumoniae and Haemophilus influenzae w re isolated from the
specimens using standard microbiological procedures. The antibacterial activity of
ethanolic extracts of ginger and bitter kola, were investigated on these pathogens using
the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration
(MBC) assays.
Results: The extracts exhibited antibacterial activity against the pathogens. The MIC
of extracts ranged from 0.0003µg/ml to 0.7µg/ml for ginger and 0.00008µg/ml, to 1.8µg/
mL for bitter kola, while MBC ranged from 0.1.35µg/ml to 2.04µg/ml for ginger and
0.135µg/ml to 4.2µg/ml for bitter kola.
Conclusion: Results indicated that extracts of ginger root and bitter kola may contain
compounds with therapeutic activity.
INTRODUCTION
Respiratory tract infections (RTIs) continue to be
a major cause of morbidity and mortality worldwide.
Infections, which are prevalent during the cold months,
are of particular importance in children, elderly people
and in those persons with reduced host defences(1).
Disease states like pneumonia, meningitis, sinusitis and
chronic bronchitis have been associated with
Staphylococcus aureus, Streptococcus pyogenes,
Streptococcus pneumoniae and Haemophilus
influenzae(2,3). Cough and colds mirror the onset of
respiratory illness, which occur in developed and
developing countries, and are far more frequent in
young children in developing (20%) than in developed
countries (4%)(4). In the tropics, a large family size
correlates with the frequency of RTIs(5). Although
there is a wide range of antibiotics for the treatment
of bacterial infections, the development of resistance
to chemotherapeutic agents, is increasingly becoming
a pressing problem(6). Other limitations of modern
chemotherapeutic drugs are their high costs and non-
availability, especially in rural areas. As a consequence,
it is necessary to search new organic molecules with
antibacterial activity; which, in addition, could be
potential sources for starting materials for the semi-
synthesis of new drugs.
African plants, in particular medicinal plants,
constitute a rich but still largely untapped pool of natural
products(7). WHO estimates indicate that 80% of the
population (mostly in developing countries) still relies
on plant-based medicines for primary health care(8).
Ginger and bitter kola have been used in Cameroon for
such clinical conditions as bronchitis, partial impotence,
cough, laryngitis, etc. by the local population, but
without supporting scientific evidence(9). Ginger has
been shown to possess other interesting pharmacological
and physiological properties. For instance, it acts as an
anti-inflamanatory, analgesic, antipyretic, antihepato-toxic
and cardiotonic substance(10).
This study is aimed at evaluating the
antibacterial ctivity of two commonly used plant
products ginger and bitter kola in Cameroon:  against
288 clinical isolates of respiratory tract pathogens
co monly affecting individuals of all ages in our
environment.
MATERIALS AND METHODS
Study Area and Subjects: The study area was Buea, in
the South West Province of Cameroon, about 1000 metres
above sea level; temperatures are low (15°C) with a relatively
high humidity, which are predisposing factors for RTIs.
A total of 333 individuals from three localities;
Bokwango, Molyko and Bolifamba, aged between 2 to 48
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years, were sampled. Participants were informed of the aim
of the study and their written consent was obtained.
Collection of Specimen: Throat swabs were taken from
persons with running nostrils, cough and/or catarrh. Samples
were collected following a previously reported method(11),
and they were immediately transported to the laboratory in
polythene bags containing ice packs at a temperature of
approximately 4¡C.
Micro-organism and Media: The following media (Oxoid,
Basingstoke, England) were used to isolate the pathogens:
crystal violet blood agar for S. pyogenes; blood agar for S.
pneumoniae, nutrient agar (supplemented with 7.5% sodium
chloride) for S. aureus and chocolate agar for H. influenzae.
After innoculation, crystal violet blood agar plates were
incubated anaerobically between 35-37¡C for two to seven
days. Other media were incubated aerobically for 24-48 hours
at 37¡C. Identification of isolates was based on their cultural,
morphological and biochemical characteristics(12).
Preparation of Ginger and Bitter Kola Extracts: The
extracts were prepared by using the method of Osuinde and
Esiovwa(13). Briefly, 3 grams of Ginger rhizomes and bitter
kola seeds were macerated separately in a clean mortar and
6ml of 95% ethanol added in the ratio 1:2(w/v). The mixtures
were allowed to stand overnight, after which extracts were
drained and evaporated to powder at 50¡C overnight. Yields
of crude ginger and bitter kola extracts were 0.0584g and
0.0407g respectively.
Determination of Minimum Inhibitory Concentration
(MIC): The MIC was determined by the tube dilution method
following the scheme reported by Koneman et al(14). Briefly,
two sets of ten tubes were prepared for each extract and
isolate. One millilitre of nutrient broth was put into the first
tubes and 9ml to the remaining nine tubes. Ten µ g each of
ginger and bitter kola were added to the first tubes respectively.
The tubes were well mixed and 1ml transferred serially until
the 10th tube. 1 x 108CFU/ml of each isolate was added to
each tube and incubated at 37¡C for 24 hours. Controls
containing only nutrient broth without extracts were included.
The MIC was regarded as the lowest concentration (highest
dilution) of extract that inhibited visible growth (no turbidity).
Determination of Minimum Bactericidal Concentration
(MBC): From each tube that did not show visible growth in
the MIC, 0.01ml was transferred into extract free nutrient
broth. After 18 hours of incubation, a loopful containing
approximately 108 CFU/ml of organism was aseptically
transferred onto nutrient agar plates. The plates were incubated
at 37¡C for 24 hours. The MBC was recorded as the lowest
concentration (highest dilution) of extract that had less than
99% growth on nutrient agar plates.
Susceptibility Testing of Pathogens to Plant Extracts
and Commercial Antibiotics: The disc diffusion method was
used as previously reported(13). The surfaces of nutrient agar
plates were flooded with 108 CFU/ml of each isolate and
drained. Sterile filter paper disc (5mm in diameter),
impregnated with extracts (10µg) were aseptically transferred
onto the surface of innoculated agar extract. Sterile discs
soaked in distilled water served as control.
Commercial antibiotic discs containing penicillin 10µg,
clindamycin 2µg, erythromycin 15µg, cefazoline 30µg,
chloramphenicol 30µg and tetracycline 30µg were transferred
onto agar plates already seeded with test organisms. Plates
were incubated at 37¡C for 24 hours and the diameters were
then compared with recorded diameters of the control
organisms, E. coli NCTC 10418 and Oxford S. aureus NCTC
6571 to determine susceptibility (‡ 12mm) or resistance
(< 6mm).
Statistical Analysis: The Chi square test was used for
statistical analysis. P values of 0.05 was considered significant.
RESULTS
Out of the 333 individuals sampled, 288 isolates
of the following organisms were isolated: S. aureus
(28.5%), S. pneumoniae (26.4%), S. pyogenes (20.1%)




Organism Bokwango Bolifamba Molyko Total(%)
S. aureus 16 21 45 82 (28.5)
S. pneumoniae 34 25 17 76 (26.4)
S. pyogenes 24 20 14 58 (20.1)
H. influenzae 26 26 20 72 (25.0)
Table 2
Antibacterial activity of ginger extract (10µg) and bitter kola extract (10µg) A
Locality S. aureus S. pneumoniae H. Influenzae S. pyogenes
Ginger Bitter kola Ginger Bitter kola Ginger Bitter kola Ginger Bitter kola
Bokwango 6 5 2 6 1 1 6 6
Molyko 4 4 3 2 4 3 5 4
Bolifamba 2 2 4 9 2 1 3 2
A= Zone of inhibition (mm)
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The plant extracts howed antibacterial ctivity
against he isolates with zones of inhibition ranging
from 1mm to 9mm (Table 2). The results of antibacterial
activity of commercial discs are shown in Table 3. The
pathogens showed resistance to five of the antibiotics
tested as indicated by the diameters of inhibition zones.
The MIC of the plant extracts ranged from 0.0003µg/
ml, to 0.7µg/ml, for ginger extract, and 0.00008µg/ml
to 1.8µg/ml for bitter kola extract (Table 4). The UBC
ranged from 0.15µg/ml to 2.04µg/ml for ginger extract
and 0.135 µg/ml for bitter kola extract (Table 5).
DISCUSSION
Plant extracts used in this study exhibited
antibacterial ctivity against all the pathogens tested.
S. aureus was most susceptible to ginger extract with
an inhibition zone diameter of 6mm, while S. pneumoniae
was most susceptible to bitter kola extract with an
inhibition zone diameter of 9mm (Table 2). There was
a significant difference (p<0.05) between the diameters
of zones of inhibition of ginger and bitter kola extracts
for each organism in the three localities. The reason(s)
for this cannot be ascertained, but we speculate that
the difference could be due to interactions between
factors related to the host, pathogens and the environment
as earlier suggested(15), as well as rate of diffusion
of the extract, culture medium, depth of the medium
and density of innoculation(16).
The activity of the ginger and bitter kola extracts
was compared with that of commercial antibiotic discs
(Table 3). Comparing the diameters of inhibition zones
obtained from the commercial antibiotics, all test
organisms were resistant to five (penicillin, erythromycin,
Table 4
MIC of ginger and bitter kola extract (µg/mL)
Locality S. aureus S. pneumoniaeH. influenzae pyogenes
Ginger Bitter Ginger Bitter Ginger Bitter Ginger Bitter
kola kola kola kola
Bokwango0.0003 1 0.4 0.0003 0.316 0.667 0.00050.0005
Molyko 0.4 1.66 0.7 1.7 0.001 0.001 0.083 0.25
Bolifamba 0.6 1.8 0.001 0.00008 0.2 1.053 0.389 0.44
Table 5
MBC of ginger and bitter kola extracts (ug/mL)
Locality S. aureus S. pneumoniaeH. influenzae S. pyogenes
Ginger Bitter Ginger Bitter Ginger Bitter Ginger Bitter
kola kola kola kola
Bokwango 0.15 3.4 0.16 0.16 0.73 1.17 0.15 0.9
Molyko 1.73 3.64 2.04 3 0.67 1 1.25 1
Bolifamba 0.24 4.2 0.15 0.135 0.63 1.42 1.44 1.11
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clindamycin, chloramphenicol and tetracycline) of the
seven antibiotics tested. They were only susceptible to
cefazoline and cefuroxime. The wide spectrum of
activity of plant extracts compared to the commercial
antibiotics is an indication of their antibacterial potential
in medicine. There are no reports of severe toxicity in
humans from eating ginger or bitter kola(10), thus
marketers of the natural fo mof the compound need
not demonstrate its safety as would be the case for a
new pharmaceutical.
The observed resistance to most of the antibiotics
was not unexpected because these drugs are relatively
cheap, and therefore commonly available to the
population who tend to abuse them heralding the
emergence of resistance(17). Meanwhile, cefazolin and
cefuroxime are more expensive and not affordable by
the local population. The demonstrable antibacterial
activity of the plant extracts to these pathogens i
therefore an interesting and important finding since they
are cheap, and easily affordable by the population.
The lowest MBC for ginger extract (0.0003µg/ml)
was recorded for S. aureus (Table 4) while the highest
MICs of ginger extract (0.7µg/ml) and bitter kola
extract (1.8µg/ml) were recorded for S. pneumoniae nd
S. aureus respectively. There was no significant
difference (p>0.05) between the MICs of ginger and
bitter kola extracts respectively in the three localities
with respect to each of the organisms. However, there
was a significant difference (p<0.05) between the MICs
of the extracts for S. pneumoniae and S. aureus each
in the three localities.
The lowest MIC for ginger extract (0.15µg/ml)
was recorded for S. aureus and S. pyogenes, while the
highest value (2.04µg/ml) was recorded for S.
pneumoniae (Table 5). S. aureus generally had low
MBC values for ginger extract compared to the other
test organisms. The highest MBC for bitter kola extract
(4.2µg/ml) was recorded for S. aureus, while the least
value (0.135µg/ml) was recorded for S. pneumoniae.
There was no significant difference (p>0.05) in the
MBC of ginger extract for S. aureus, H. influenzae  and
S. pyogenes each in  the three localities. The difference
between the MBC of bitter kola extract for S influenzae
and S. pyogenes each in the three localities was not
significant (p>0.05), but was significant (p<0.05) for
S. aureus.
These differences observed could be attributed to
the fact that serotypes of pneumococci vary
geographically and are subject to antigenic changes as
previously reported(18). In addition, the phenomenon
of tolerance due to recurrent infections, caused by
overcrowding which is a crucial variable associated
with risk of streptococcal infections could be a
contributing factor(19). Furthermore, this could be due
to the age or diet of the subjects in this study since
age and diet are apparent risk factors, which may
change the adaptive response of an infecting micro-
organism.
In conclusion, the results of this study indicate that
ging r and bitter kola extracts could be better options
to some of the antibiotics commonly used for respiratory
tract nfections in the environment of Buea, Cameroon.
Th se findings, therefore, are of great significance and
could be clinically exploited.
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